DNA vaccination efficiently induces antibodies to Nogo-A and does not exacerbate experimental autoimmune encephalomyelitis

Immunology and Microbiology

• Experimental Autoimmune Encephalomyelitis 100%
• DNA Vaccination 100%
• DNA Immunization 100%
• Peptides 40%
• Plasmid 20%
• Western Blot 20%
• Inflammation Response 20%
• Central Nervous System 20%
• Pathogenic Potential 20%
• Mouse Model 20%
• Cell Culture 20%
• Multiple Sclerosis 20%
• Amino Terminal Sequence 20%
• ELISA 20%
• Antibody Response 20%
• Antibody Blood Level 20%
• Expression Vector 20%
• Spinal Cord 20%
• Neurite Outgrowth 20%
• Myelin Oligodendrocyte Glycoprotein 20%
• Myelin 20%
• Pathogenicity 20%
• Antibodies 20%

Keyphrases

• Nogo-A 100%
• DNA Vaccination 100%
• Experimental Autoimmune Encephalomyelitis 100%
• Immunohistochemistry 10%
• Spinal Cord Injury 10%
• Cell Culture 10%
• Inflammatory Response 10%
• Disease Severity 10%
• Multiple Sclerosis 10%
• Pathogenicity 10%
• Central Nervous System 10%
• Mouse Model 10%
• Antibody Response 10%
• Vaccination 10%
• Western Blotting 10%
• Recombinant 10%
• Plasmid 10%
• After Injection 10%
• Immunization 10%
• Specific Antibodies 10%
• Signal Peptide 10%
• Expression Vector 10%
• Induced Production 10%
• Serum Antibody 10%
• Myelin 10%
• Myelin Oligodendrocyte Glycoprotein 10%
• DNA Encoding 10%
• Axonal Regeneration 10%
• Clinical Severity 10%
• Pathogenic Potential 10%
• Oligodendrocyte 10%
• Neurite Outgrowth inhibitor-A 10%
• Vector Encoding 10%
• Proteolipids 10%
• CNS Inflammation 10%